Jim Cramer's Charitable Trust made a strategic move, increasing its position in Bristol Myers Squibb while selling a portion of its Starbucks holdings. The trades reflect Cramer's confidence in BMY's long-term prospects, particularly the potential of its schizophrenia drug Cobenfy, and a decision to take profits on the Starbucks turnaround.
Jim Cramer's Charitable Trust has made two recent trades, adding to its position in Bristol Myers Squibb (BMY) and selling a portion of its Starbucks (SBUX) holdings. The trust purchased 300 shares of BMY at roughly $55.44, increasing its ownership to 1,800 shares and boosting its weighting to about 2.7% from 2.25%. Concurrently, it sold 100 shares of SBUX at approximately $111.48, reducing its stake to 1,000 shares and lowering its weighting to about 3% from 3.35%.
These trades follow a period of trading restrictions imposed after Jim Cramer mentions a stock on CNBC TV. The restrictions prevent trading the stock for 72 hours. Cramer highlighted the recent sell-off in BMY shares, attributing it to concerns about generic competition and foreign exchange headwinds. Despite these factors, Cramer remains bullish on BMY, citing the upcoming trial readouts for its schizophrenia drug Cobenfy as catalysts for growth. He also pointed to the company's low price-to-earnings valuation and 4.4% dividend yield as attractive factors. Regarding SBUX, Cramer acknowledged the impressive turnaround under CEO Brian Niccol but opted to take profits due to the inherent challenges of sustaining a turnaround. The sale realizes a gain of approximately 30% on shares purchased in August 2022
INVESTING TRADES BRISTOL MYERS SQUIBB STARBUCKS JIM CRAMER CHARITABLE TRUST STOCK MARKET TURNAROUND COBENFY
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Jim Cramer's Charitable Trust Makes Three Trades: Coterra Energy, Honeywell, and Eli LillyJim Cramer's Charitable Trust announced three trades on Tuesday, selling 200 shares of Coterra Energy, 45 shares of Honeywell, and buying 10 shares of Eli Lilly. The Trust is trimming its positions in Coterra and Honeywell while increasing its stake in Eli Lilly.
Read more »
Jim Cramer's Charitable Trust Sells Stanley Black & Decker SharesJim Cramer's Charitable Trust is selling 250 shares of Stanley Black & Decker (SWK) at approximately $90.54, reducing its stake and capitalizing on the recent market strength.
Read more »
Jim Cramer's Charitable Trust Takes Profits in GE HealthcareJim Cramer's Charitable Trust is selling 75 shares of GE Healthcare (GEHC) at approximately $90 per share, reducing its weighting to 2.25%. This decision follows a strong performance in GEHC in 2025 and reflects the market's rotation toward healthcare stocks.
Read more »
Jim Cramer's Charitable Trust Buys More BlackRock Amid Fee WarJim Cramer's Charitable Trust increases its stake in BlackRock (BLK) following Vanguard's announcement of fee reductions on several funds. While the move puts pressure on asset managers, Cramer believes the market's reaction to BlackRock's decline is overblown and highlights the company's focus on private markets as a growth strategy.
Read more »
Jim Cramer's Charitable Trust Sells Abbott Shares After Strong RallyJim Cramer's Charitable Trust trims its position in Abbott Laboratories (ABT) after a significant price surge driven by strong earnings and a positive outlook for 2025 sales growth.
Read more »
Jim Cramer explains how better management can change a stock's fateCNBC's Jim Cramer highlighted CEOs from Starbucks, Chili's parent Brinker International and General Electric.
Read more »